Vitamin D insufficiency and deficiency in chronic kidney disease: A single center observational study

American Journal of Nephrology

Volumn 24, Issue 5, 2004, Pages 503-510

  González, Esther A ^a   Sachdeva, Ashutosh ^a   Oliver, Dana A ^a   Martin, Kevin J ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Chronic kidney disease; End stage renal disease; Vitamin D

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCITRIOL; PARATHYROID HORMONE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CALCULATION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; FEMALE; GLOMERULUS FILTRATION; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; UNITED STATES; VITAMIN D DEFICIENCY;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 10644280669     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081023     Document Type: Article

References (39)

1. Martin KJ, Gonzalez EA, Slatopolsky E: Renal osteodystrophy; in Brenner BM, Rector FC (eds): The Kidney. Philadelphia, Saunders, 2004, pp 2255-2304.
2. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ: Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7:439-443.
3. Tangpricha V, Pearce EN, Chen TC, Holick MF: Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002;112:659-662.
4. Van der Wielen RP, Lowik MR, van den Berg H, de Groot LC, Haller J, Moreiras O, van Staveren WA: Serum vitamin D concentrations among elderly people in Europe. Lancet 1995;346:207-210.
5. Dawson-Hughes B, Harris SS, Dallal GE: Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 1997;65:67-71.
6. Passeri G, Pini G, Troiano L, Vescovini R, Sansoni P, Passeri M, Gueresi P, Delsignore R, Pedrazzoni M, Franceschi C: Low vitamin D status, high bone turnover, and bone fractures in centenarians. J Clin Endocrinol Metab 2003;88:5109-5115.
7. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS: Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777-783.
8. Cannata-Andia JB, Gomez Alonso C: Vitamin D deficiency: A neglected aspect of disturbed calcium metabolism in renal failure. Nephrol Dial Transplant 2002;17:1875-1878.
9. Fournier A, Fardellone P, Achard JM, Ghazali A, Pruna A, El Esper N, Moriniere P: Importance of vitamin D repletion in uraemia. Nephrol Dial Transplant 1999;14:819-823.
10. Eknoyan G, Levin A, Levin NW: Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:1-201.
11. Docio S, Riancho JA, Perez A, Olmos JM, Amado JA, Gonzalez-Macias J: Seasonal deficiency of vitamin D in children: A potential target for osteoporosis-preventing strategies? J Bone Miner Res 1998;13:544-548.
12. 3 or 1,25-dihydroxycholecalciferol. Lancet 1980;ii:612-615.
13. Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H: Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 1999;55:1019-1027.
14. Ghazali A, Fardellone P, Pruna A, Atik A, Achard JM, Oprisiu R, Brazier M, Remond A, Moriniere P, Garabedian M, Eastwood J, Fournier A: Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 1999;55:2169-2177.
15. 3. J Clin Endocrinol Metab 1984;59:1063-1069.
16. Dusso A, Lopez-Hilker S, Rapp N, Slatopolsky E: Extra-renal production of calcitriol in chronic renal failure. Kidney Int 1988;34:368-375.
17. Reichel H, Deibert B, Schmidt-Gayk H, Ritz E: Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant 1991;6:162-169.
18. Messa P, Vallone C, Mioni G, Geatti O, Turrin D, Passoni N, Cruciatti A: Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients. Kidney Int 1994;46:1713-1720.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
20. Bayard F, Bec P, Ton That H, Louvet JP: Plasma 25-hydroxycholecalciferol in chronic renal failure. Eur J Clin Invest 1973;3:447-450.
21. Saha H: Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol 1994;41:290-296.
22. Hollis BW, Jacob AI, Sallman A, Santiz Z, Lambert PW: Circulating vitamin D and its photoproduction in uremia; in Norman AW, et al (eds): Vitamin D: Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism. Berlin, de Gruyter, 1982, pp 1157-1161.
23. Holick MF: Vitamin D and the kidney. Kidney Int 1987;32:912-929.
24. Loomis WF: Skin-pigment regulation of vitamin-D biosynthesis in man. Science 1967;157:501-506.
25. 3. J Clin Invest 1985;76:1536-1538.
26. 3. Cell 1999;96:507-515.
27. 3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-1642.
28. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T: A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001;86:1212-1221.
29. Dhesi JK, Bearne LM, Moniz C, Hurley MV, Jackson SH, Swift CG, Allain TJ: Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 2002;17:891-897.
30. Visser M, Deeg DJ, Lips P: Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003;88:5766-5772.
31. Plotnikoff GA, Quigley JM: Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003;78:1463-1470.
32. 3. Cancer Epidemiol Biomarkers Prev 1998;7:391-395.
33. 3-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001;86:888-894.
34. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA, Chakraverty R: Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003;170:5382-5390.
35. 2) insufficiency and deficiency and relationship to hyperparathyroidism by crosssectional analysis in a geographically diverse stage 3 and 4 CKD patient population (abstract). J Am Soc Nephrol 2003;14:199A.
36. Fournier A, Bordier P, Gueris J, Sebert JL, Marie P, Ferriere C, Bedrossian J, DeLuca HF: Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: Greater effect of 25-hydroxycholecalciferol on bone mineralization. Kidney Int 1979;15:196-204.
37. 3. Kidney Int Suppl 1988;24:S178-S179.
38. 3 in the osteomalacia of chronic renal failure. Clin Sci Mol Med 1977;52:499-508.
39. Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-856.